Pre-clinicals have shown that BA79 can increase the stool volume, fecal water content, food intake and body weight of rats, reduce the vasoactive intestinal peptide VIP in the serum that inhibits gastric motility, and can also significantly improve the operating efficiency of the gastrointestinal tract and regulate intestinal flora, promote nutrient absorption. At the same time, BA79 has strong inhibitory ability against pathogenic bacteria and the ability to utilize functional oligosaccharides.

Animal experiments show that LC16 can significantly increase rat bone density, promote calcium absorption, and rat osteoblast proliferation, inhibit osteoclasts, regulate bone metabolism, reduce the risk of osteoporosis, and improve bone health. At the same time, LC16 can produce short-chain fatty acids, lower the local pH value of the intestine, reduce the formation of complexes between intestinal calcium ions and phosphorus, and promote calcium absorption.

It can convert linoleic acid into conjugated linoleic acid with a high conversion rate. Conjugated linoleic acid has important health functions, such as improving immunity, antioxidant, anti-tumor, anti-atherosclerosis, weight loss, etc.

Pre-clinicals show that BL21 can inhibit intestinal flora disorders, improve the metabolism of intestinal flora, and has the potential to promote nutrient absorption and utilization. At the same time, BL21 has strong acid and bile salt resistance and can reach the intestines smoothly. The extracellular polysaccharide it produces also has antioxidant and other functions.

It has a strong ability to synthesize γ-aminobutyric acid, which can effectively lower blood pressure, has sedative and hypnotic effects, delays neural aging, and can play a good role in improving sleep. At the same time, ST36 can regulate the balance of intestinal flora, relieve stress, and benefit physical and mental health.